Korczynski Sherry (CIK 2026090) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-09). Recent activity: Sell AQST (2,714 shares), Buy AQST (75,000 shares), Sell AQST (15,741 shares), Buy AQST (25,000 shares), Sell AQST (2,714 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-09 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | Sell | 2,714 | $0 |
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | Buy | 75,000 | $0 |
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | Sell | 15,741 | $65,640 |
| 2025-08-15 | Aquestive Therapeutics, Inc. (AQST) | Chief Commercial Officer | Buy | 25,000 | $0 |
| 2025-06-10 | Aquestive Therapeutics, Inc. (AQST) | SVP Sales and Marketing | Sell | 2,714 | $9,608 |
| 2025-03-11 | Aquestive Therapeutics, Inc. (AQST) | SVP Sales and Marketing | Buy | 90,000 | $0 |
| 2025-03-11 | Aquestive Therapeutics, Inc. (AQST) | SVP Sales and Marketing | Sell | 5,428 | $14,384 |
Source: SEC Form 4 filings · as of 2026-06-09